X4 Pharmaceuticals, Inc. (XFOR)
3.72
-0.13
(-3.38%)
USD |
NASDAQ |
Jun 10, 16:00
3.72
0.00 (0.00%)
After-Hours: 20:00
X4 Pharmaceuticals Market Cap : 350.87M for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 09, 2026 | 363.13M |
| June 08, 2026 | 349.93M |
| June 05, 2026 | 361.24M |
| June 04, 2026 | 378.22M |
| June 03, 2026 | 374.45M |
| June 02, 2026 | 381.05M |
| June 01, 2026 | 387.65M |
| May 29, 2026 | 406.52M |
| May 28, 2026 | 390.48M |
| May 27, 2026 | 380.11M |
| May 26, 2026 | 377.28M |
| May 22, 2026 | 381.05M |
| May 21, 2026 | 381.05M |
| May 20, 2026 | 355.59M |
| May 19, 2026 | 343.32M |
| May 18, 2026 | 347.10M |
| May 15, 2026 | 371.62M |
| May 14, 2026 | 377.28M |
| May 13, 2026 | 398.97M |
| May 12, 2026 | 409.35M |
| May 11, 2026 | 424.44M |
| May 08, 2026 | 417.84M |
| May 07, 2026 | 404.63M |
| May 06, 2026 | 413.12M |
| May 05, 2026 | 396.14M |
| Date | Value |
|---|---|
| May 04, 2026 | 397.09M |
| May 01, 2026 | 380.95M |
| April 30, 2026 | 370.04M |
| April 29, 2026 | 372.77M |
| April 28, 2026 | 374.59M |
| April 27, 2026 | 382.77M |
| April 24, 2026 | 373.68M |
| April 23, 2026 | 389.14M |
| April 22, 2026 | 401.87M |
| April 21, 2026 | 379.14M |
| April 20, 2026 | 380.95M |
| April 17, 2026 | 390.05M |
| April 16, 2026 | 376.41M |
| April 15, 2026 | 393.68M |
| April 14, 2026 | 381.86M |
| April 13, 2026 | 375.50M |
| April 10, 2026 | 372.77M |
| April 09, 2026 | 370.04M |
| April 08, 2026 | 368.22M |
| April 07, 2026 | 339.13M |
| April 06, 2026 | 370.04M |
| April 02, 2026 | 385.50M |
| April 01, 2026 | 395.50M |
| March 31, 2026 | 375.50M |
| March 30, 2026 | 362.77M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Kyverna Therapeutics, Inc. | 463.07M |
| Arrowhead Pharmaceuticals, Inc. | 9.938B |
| Oncolytics Biotech, Inc. | 93.29M |
| Sangamo Therapeutics, Inc. | 62.20M |
| Sarepta Therapeutics, Inc. | 1.596B |
Market Cap Related Metrics
| PS Ratio | 29.67 |
| Price to Book Value | 2.083 |
| Price | 3.72 |
| Earnings Yield | -122.0% |